Moderna Inc (MRNA)
Operating return on assets (Operating ROA)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | -3,945,000 | -2,693,000 | -4,635,000 | -5,139,000 | -4,239,000 | -2,665,000 | 513,000 | 4,827,000 | 9,420,000 | 13,250,000 | 15,642,000 | 16,257,000 | 13,296,000 | 7,610,962 | 3,817,845 | 633,718 | -763,144 | -618,662 | -514,402 | -536,211 |
Total assets | US$ in thousands | 14,142,000 | 15,803,000 | 15,680,000 | 16,729,000 | 18,426,000 | 19,450,000 | 21,884,000 | 24,125,000 | 25,858,000 | 26,056,000 | 26,043,000 | 27,609,000 | 24,669,000 | 20,923,000 | 16,153,000 | 12,694,000 | 7,337,000 | 4,650,870 | 3,486,010 | 2,067,540 |
Operating ROA | -27.90% | -17.04% | -29.56% | -30.72% | -23.01% | -13.70% | 2.34% | 20.01% | 36.43% | 50.85% | 60.06% | 58.88% | 53.90% | 36.38% | 23.64% | 4.99% | -10.40% | -13.30% | -14.76% | -25.93% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $-3,945,000K ÷ $14,142,000K
= -27.90%
Operating return on assets (Operating ROA) is a key financial ratio that measures a company's ability to generate profit from its operating activities relative to its total assets. Moderna Inc's Operating ROA has shown a fluctuating trend over the analyzed periods.
- The performance was notably poor in the first half of 2020, with negative Operating ROA figures indicating the company was not effectively utilizing its assets to generate operating profits.
- However, the situation improved significantly starting from March 2021, when the Operating ROA turned positive and showed a steady upward trajectory until June 2022. This period marked a strong performance where Moderna Inc was able to effectively generate profits from its operating activities in relation to its assets.
- From September 2022 onwards, there was a slight decline in the Operating ROA, although it remained relatively high compared to the earlier negative figures. This period still showed Moderna Inc's ability to efficiently utilize its assets to generate operating profits, albeit at a slightly lower rate.
- The most recent data available, as of December 31, 2024, indicates a decrease in the Operating ROA, returning to negative figures. This suggests a decline in the company's ability to generate profits from its operating activities in relation to its total assets, signaling a potential challenge in efficiently utilizing its assets.
Overall, Moderna Inc's Operating ROA has demonstrated both periods of strong performance and challenges, indicating the company's varying efficiency in generating profits from its operating activities in relation to its total assets over the analyzed time frame.
Peer comparison
Dec 31, 2024